Multiplikator Forward P/S: Nevro (NVRO)
Nevro Corp. profitability is supported by stable demand, although geopolitics and sanctions create risks for supply chains. The issuer's forward P/S visualizes the market valuation, where 0.50 represents the current level of the metric. The business relies on lifetime implant maintenance, and the sector's independence from macroeconomics turns the company into a reliable defensive asset.
Ringkesan rincian data analitis Nevro Medical (NVRO)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Nevro Corp.|NVRO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Nevro Corp.|NVRO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Nevro Medical|NVRO - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Nevro|Rasio cepet nevro.com
- rincian asil keuangan lan kelipatan valuasi:
NVRO - Penghasilan resik perusahaan|Bathi sing dikarepake Nevro Corp.|NVRO - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Nevro Corporation|NVRO - Pangali PEG|Pangali EV/EBITDA Nevro Medical|NVRO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Nevro|NVRO - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nevro.com|NVRO - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Nevro Corp.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:NVRO (Nevro)
For Nevro Corp. (NVRO), which operates in the neurostimulator segment, the forward P/S reflects the market value relative to expected sales of pain treatment systems. By analyzing the trajectory of the forward P/S, an investor assesses the premium for future revenue growth in med-tech; the multiplier approaching the upper bounds of its historical range signals that the asset is overbought and indicates risks of a capital correction.
Karo sapa Nevro Corp. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|ibs.inc (INBS) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan XAIR|PFSA (Profusa) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep STRATA Skin SSKN|Multiplikator forward rega marang pendapatan GCTK (GlucoTrack)|Rasio rega marang prakiraan pendapatan NAOV (NanoVibronix Inc.)|Rasio rega marang prakiraan pendapatan Venus Concept Inc. VERO|Rega forward marang dodolan NUWE|AEMD - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Asensus Surgical, Inc.|AVGR (Avinger, Inc) - Multiplikator forward rega marang pendapatan|Biosig Technologies - Rega forward marang dodolan|CUTR (Cutera, Inc.) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan knowlabs.co (KNW)|Rasio rega marang prakiraan pendapatan Inari Medical (NARI)|RSLS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
